Discontinuation of Disease-Modifying Therapy in Multiple Sclerosis: Should We Stay or Should We Go?

Eva M. M. Strijbis, Anne Kerbrat, John R. Corboy

Research output: Contribution to journal › Comment/Letter to the editor › Academic

5 Citations (Scopus)

Original language	English
Pages (from-to)	787-788
Number of pages	2
Journal	JAMA Neurology
Volume	78
Issue number	7
Early online date	2021
DOIs	https://doi.org/10.1001/jamaneurol.2021.0764
Publication status	Published - Jul 2021

Access to Document

https://doi.org/10.1001/jamaneurol.2021.0764

Other files and links

Link to publication in Scopus

Cite this

@article{d235a7168c3e42b9a692fe38155f3894,

title = "Discontinuation of Disease-Modifying Therapy in Multiple Sclerosis: Should We Stay or Should We Go?",

author = "Strijbis, {Eva M. M.} and Anne Kerbrat and Corboy, {John R.}",

note = "Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2021",

month = jul,

doi = "https://doi.org/10.1001/jamaneurol.2021.0764",

language = "English",

volume = "78",

pages = "787--788",

journal = "JAMA Neurology",

issn = "2168-6149",

publisher = "American Medical Association",

number = "7",

}

TY - JOUR

T1 - Discontinuation of Disease-Modifying Therapy in Multiple Sclerosis: Should We Stay or Should We Go?

AU - Strijbis, Eva M. M.

AU - Kerbrat, Anne

AU - Corboy, John R.

N1 - Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/7

Y1 - 2021/7

UR - http://www.scopus.com/inward/record.url?scp=85104415425&partnerID=8YFLogxK

U2 - https://doi.org/10.1001/jamaneurol.2021.0764

DO - https://doi.org/10.1001/jamaneurol.2021.0764

M3 - Comment/Letter to the editor

C2 - 33871561

SN - 2168-6149

VL - 78

SP - 787

EP - 788

JO - JAMA Neurology

JF - JAMA Neurology

IS - 7

ER -